+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Medical Simulation Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon


  • 140 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5912194
The global medical simulation market size reached US$ 2.2 Billion in 2022. Looking forward, the market is expected to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 13.49% during 2022-2028.

Medical simulation refers to the virtual duplication of in-situ activities for training, feedback and experiential learning. It is commonly used by physicians, nurses, surgeons and other practitioners under training to learn, practice and assess their skills in a safe environment. Medical simulation uses body manikins, task trainers and virtual reality (VR)-based systems for laparoscopic, gynecological, cardiovascular, arthroscopic, spinal, endovascular, dental and eye simulation. It provides feedback from observers, such as professors, peers, actor-patients and video cameras, and aids in enhancing patient safety, optimizing communications and improving crisis resource management. As a result, it finds extensive applications across hospitals, academic institutes, military organizations, research facilities and ambulatory care centers.

Medical Simulation Market Trends

Significant growth in the medical industry across the globe is among the key factors creating a positive outlook for the market. Moreover, the increasing awareness regarding the benefits of simulation-based learning among the masses is providing a thrust to the market growth. In line with this, the widespread adoption of laparoscopic simulation systems for effective cancer treatment is also contributing to the market growth. Various technological advancements, such as the integration of augmented reality (AR), robotics and artificial intelligence (AI) solutions in interventional simulators, are acting as other growth-inducing factors. These simulators are extensively used for training physicians in conducting cholecystectomy, appendectomy, gastric bypass, tubal ligation and hysterectomy. Other factors, including the rising concerns regarding patient safety, along with rapid digitization of the healthcare industry, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global medical simulation market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product and services, fidelity and end user.

Breakup by Product and Services:

  • Model-based Simulation
  • Surgical Simulation
  • Ultrasound Simulation
  • Web-based Simulation
  • Simulation Training Services

Breakup by Fidelity:

  • Low Fidelity
  • Medium Fidelity
  • High Fidelity

Breakup by End User:

  • Hospitals and Clinics
  • Academic Institutions and Research Centers
  • Military Organizations

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cardionics Inc. (3B Scientific GmbH), Gaumard Scientific Company Inc., Kyoto Kagaku Co. Ltd, Laerdal Medical, Mentice, Operative Experience Inc., Simbionix USA Corporation (3D Systems), Simulab Corporation, Surgical Science Sweden AB, Synaptive Medical Inc., SynBone AG and VirtaMed AG.

Key Questions Answered in This Report:

  • How has the global medical simulation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global medical simulation market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product and services?
  • What is the breakup of the market based on the fidelity?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global medical simulation market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Medical Simulation Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product and Services
6.1 Model-based Simulation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Surgical Simulation
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Ultrasound Simulation
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Web-based Simulation
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Simulation Training Services
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Fidelity
7.1 Low Fidelity
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Medium Fidelity
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 High Fidelity
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Academic Institutions and Research Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Military Organizations
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States Market Trends Market Forecast
9.1.2 Canada Market Trends Market Forecast
9.2 Asia-Pacific
9.2.1 China Market Trends Market Forecast
9.2.2 Japan Market Trends Market Forecast
9.2.3 India Market Trends Market Forecast
9.2.4 South Korea Market Trends Market Forecast
9.2.5 Australia Market Trends Market Forecast
9.2.6 Indonesia Market Trends Market Forecast
9.2.7 Others Market Trends Market Forecast
9.3 Europe
9.3.1 Germany Market Trends Market Forecast
9.3.2 France Market Trends Market Forecast
9.3.3 United Kingdom Market Trends Market Forecast
9.3.4 Italy Market Trends Market Forecast
9.3.5 Spain Market Trends Market Forecast
9.3.6 Russia Market Trends Market Forecast
9.3.7 Others Market Trends Market Forecast
9.4 Latin America
9.4.1 Brazil Market Trends Market Forecast
9.4.2 Mexico Market Trends Market Forecast
9.4.3 Others Market Trends Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Cardionics Inc. (3B Scientific GmbH) Company Overview Product Portfolio
14.3.2 Gaumard Scientific Company Inc. Company Overview Product Portfolio
14.3.3 Kyoto Kagaku Co. Ltd Company Overview Product Portfolio
14.3.4 Laerdal Medical Company Overview Product Portfolio SWOT Analysis
14.3.5 Mentice Company Overview Product Portfolio Financials
14.3.6 Operative Experience Inc. Company Overview Product Portfolio Financials
14.3.7 Simbionix USA Corporation (3D Systems) Company Overview Product Portfolio
14.3.8 Simulab Corporation Company Overview Product Portfolio
14.3.9 Surgical Science Sweden AB Company Overview Product Portfolio Financials
14.3.10 Synaptive Medical Inc. Company Overview Product Portfolio
14.3.11 SynBone AG Company Overview Product Portfolio
14.3.12 VirtaMed AG Company Overview Product Portfolio

Companies Mentioned

  • Cardionics Inc. (3B Scientific GmbH)
  • Gaumard Scientific Company Inc.
  • Kyoto Kagaku Co. Ltd
  • Laerdal Medical
  • Mentice
  • Operative Experience Inc.
  • Simbionix USA Corporation (3D Systems)
  • Simulab Corporation
  • Surgical Science Sweden AB
  • Synaptive Medical Inc.
  • SynBone AG
  • VirtaMed AG



Table Information